AlQassimi S, et al. - Given that psoriasis is a common disease that has not only cutaneous manifestations but also causes significant systemic illness and disability, researchers conducted this investigation to analyze the detailed description of the worldwide burden of psoriasis. They examined the prevalence, incidence, disability adjusted life years, and years lived with disability related to psoriasis for the period 1990 to 2017, from the Global Burden of Disease dataset (developed by the Institute of Health Metrics, University of Washington). The global age‐standardized prevalence rate of psoriasis in 2017 was 811 per 100,000 population, approximately 0.84% of world population or nearly 64.6 million people. The rate of new cases rose from 92 per 100,000 in 1990 to 99 in 2017. North America and Western Europe reported the highest rates whereas the lowest rates were found in Asia and the Western Pacific regions. The distribution of age shows a rising incidence rate from the second decade, peaking at 55–60 years. Women have a significantly greater risk of being affected. Over the last three decades, the global incidence of psoriasis has increased. The burden of psoriasis induced economic and psychosocial distress needs resource allocation and a multidisciplinary approach to treating this common medical condition.